# Proximie

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/proximie

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.proximie.com
- Total disclosed funding: $111M
- Latest round: Series C (Apr 26, 2022)
- Investors on record: 15

## About

Based in the UK, Proximie Limited operates a cloud-based platform that enhances surgical procedures by enabling real-time collaboration and data analysis for healthcare professionals.Proximie Limited is a technology company that focuses on transforming operating rooms into interconnected ecosystems through its innovative software platform. Founded in 2016 and headquartered in London, UK, the company has successfully raised GBP 57.75 mn in its most recent funding round, Series C, on April 26, 2022. The funding round was led by Advent Life Sciences, with participation from various investors, including British Patient Capital and Mubadala Capital. The founder, Nadine Haram, has a history in the healthcare technology sector, driving the company's efforts towards enhancing surgical training and operational efficiency.Proximie offers a cloud-based software platform designed to enhance the functionality and connectivity of operating rooms and medical devices, facilitating real-time collaboration and data analysis. The platform enables healthcare providers and medical device companies to optimize workflows and improve patient safety through telepresence capabilities and AI-driven insights. Proximie caters to hospitals, surgical centers, and medical device manufacturers, aiming to elevate productivity and innovation in the surgical environment.In the most recent fiscal year of 2022, Proximie reported a revenue of GBP 3,674,493, while incurring an EBITDA loss of GBP 23,527,388. The company generates revenue primarily through subscription services, partnering with healthcare organizations to provide tiered access to its software features, aimed at improving operational efficiency.Following its Series C funding round in April 2022, Proximie Limited aims to accelerate the development of its products and expand its market ecosystem. The funding will be utilized to enhance the operating system of the operating room, which serves as a centralized platform for connected surgical treatment. The company plans to explore new geographic markets to broaden its reach, focusing on North America, Europe, and Asia. Proximie's strategy emphasizes developing key products and services tailored to meet the evolving needs of healthcare providers.

## Funding rounds

- Series C, Apr 26, 2022, $73M — Eight Roads Ventures, F-Prime Capital, Maverick Capital, Questa Capital, Advent Life Sciences, SB Investment Advisers, Mubadala Capital, Emerson Collective, British Patient Capital, Global Ventures, Minderoo Foundation
- Series B, Apr 1, 2021, $35M — Eight Roads Ventures, F-Prime Capital, Maverick Capital, BECO Capital, Questa Capital, Global Ventures, Cedar Mundi Ventures
- Series A, Apr 18, 2019, $3.5M — Endeavor Catalyst, BECO Capital, Draper, Global Ventures, Cedar Mundi Ventures
- Seed, Oct 20, 2016 — Cedar Mundi Ventures

## Investors

- Cedar Mundi Ventures (https://capitalatlas.ai/funds/cedar-mundi-ventures) — Seed, Series A, Series B
- Endeavor Catalyst (https://capitalatlas.ai/funds/endeavor-catalyst) — Series A
- BECO Capital (https://capitalatlas.ai/funds/beco-capital) — Series A, Series B
- Draper (https://capitalatlas.ai/funds/draper) — Series A
- Global Ventures (https://capitalatlas.ai/funds/global-ventures) — Series A, Series B, Series C
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series B, Series C
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series B, Series C
- Maverick Capital (https://capitalatlas.ai/funds/maverick-capital) — Series B, Series C
- Questa Capital (https://capitalatlas.ai/funds/questa-capital) — Series B, Series C
- Advent Life Sciences (https://capitalatlas.ai/funds/advent-life-sciences) — Series C
- SB Investment Advisers (https://capitalatlas.ai/funds/sb-investment-advisers) — Series C
- Mubadala Capital (https://capitalatlas.ai/funds/mubadala-capital) — Series C
- Emerson Collective — Series C
- British Patient Capital — Series C
- Minderoo Foundation — Series C